KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Current Deferred Revenue (2018 - 2025)

Historic Current Deferred Revenue for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to $2.5 million.

  • ClearPoint Neuro's Current Deferred Revenue rose 9872.2% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 9872.2%. This contributed to the annual value of $2.6 million for FY2024, which is 214.31% down from last year.
  • ClearPoint Neuro's Current Deferred Revenue amounted to $2.5 million in Q3 2025, which was up 9872.2% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, ClearPoint Neuro's Current Deferred Revenue registered a high of $2.6 million during Q4 2023, and its lowest value of $368000.0 during Q2 2021.
  • In the last 5 years, ClearPoint Neuro's Current Deferred Revenue had a median value of $1.2 million in 2023 and averaged $1.3 million.
  • In the last 5 years, ClearPoint Neuro's Current Deferred Revenue tumbled by 4159.57% in 2021 and then surged by 13678.37% in 2023.
  • Over the past 5 years, ClearPoint Neuro's Current Deferred Revenue (Quarter) stood at $678000.0 in 2021, then surged by 114.9% to $1.5 million in 2022, then soared by 79.34% to $2.6 million in 2023, then decreased by 2.14% to $2.6 million in 2024, then dropped by 2.7% to $2.5 million in 2025.
  • Its Current Deferred Revenue stands at $2.5 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.0 million for Q1 2025.